SynthesisJournal of cancer research and clinical oncology2023

Efficacy and safety of atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a systematic review and meta-analysis.

Junning Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.